Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric Carboxymaltose vs Oral Iron in Metastatic CRC
NCT02469480Phase 2Completed
- Sponsor
- Institut für Klinische Krebsforschung
- Start
- Mar 2015
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by Institut für Klinische Krebsforschung. Started Mar 2015; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT02469480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02469480.